Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $1.68, $0.02 better than the analyst estimate of $1.66. Revenue for the quarter came in at $17.5 billion versus the consensus estimate of $17.5 billion.

Guidance:

Johnson & Johnson sees FY2016 EPS of $6.53 - $6.68, versus prior guidance of $6.43 - $6.58 and the consensus of $6.54. Johnson & Johnson sees FY2016 revenue of $71.2 - $71.9 billion, versus prior guidance of $70.8 - $71.5 billion and the consensus of $71.6 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.